Recent Press Releases

New Online Resource Available Specifically for Patients and Their Caregivers Following a Heart Stent Procedure

PARSIPPANY, N.J. and INDIANAPOLIS, Jan. 18, 2011 /PRNewswire/ -- Today, patient support group Mended Hearts, in partnership with Daiichi Sankyo, Inc. and Eli Lilly and Company, launched the Stent Hub

DBV Technologies elects George Horner as non-executive Chairman of the Board of Directors to advance the clinical developm

“George Horner’s 40 years of pharmaceutical industry experience will be a considerable asset to the further development of our VIASKIN® technology, which offers a whole new paradigm for the treatment

Antitrust: Commission launches second monitoring exercise of patent settlements in pharma sector

Antitrust: Commission launches second monitoring exercise of patent settlements in pharma sector The European Commission has addressed information requests to selected pharmaceutical companies,

Catalent Clinical Supply Services Enhances Direct Global Comparator Sourcing Network

Global Network of Specialists Enhances Its Full Range of Clinical Supply Services to Ensure Reliable Supply, Timely Delivery and Competitive Pricing for Comparator Drug Sourcing Jan 17, 2011 -

Fairfield Group Introduces Cost Effective Pharmaceutical Packaging Solution with Multi-Scan Capability

Droitwich Spa, Worcestershire, United Kingdom, 01/17/2011 - As Turkey, France and California become the first to move to 2D data matrix barcodes on pharmaceutical packaging, Fairfield launch a cost

GlaxoSmithKline announces Q4 2010 legal charge

GlaxoSmithKline (GSK) today announces that it expects to record a legal charge for the fourth quarter of 2010 of £2.2 billion ($3.4 billion) (equating to an after tax cost of £1.8

Johnson & Johnson Provides Update on McNeil Consumer Healthcare Remediation

Johnson & Johnson Provides Update on McNeil Consumer Healthcare Remediation; Announces Completion of Internal Assessment Phase Of Comprehensive Action Plan McNeil Consumer Healthcare Division of

Aegis Unveils Discoverant 4.0 Enterprise Manufacturing Intelligence Software

Latest Version Leverages Microsoft SharePoint for Improved Global Collaboration LAFAYETTE, Colo.--(BUSINESS WIRE)-- Aegis Analytical Corp., the leading provider of Enterprise Manufacturing and

First Hotspur Peripheral Angioplasty Case Completed

Expanded Use Continues to Demonstrate Versatility of Hotspur's DevicesMOUNTAIN VIEW, Calif., Jan. 18, 2011 /PRNewswire/ -- Hotspur Technologies, Inc. announced today that Dr. Greg Sampognaro,

Natural Menopause Remedy and Cure, DON'T PAUSE, Helps in Fighting Menopause Symptoms

BEVERLY HILLS, Calif., Jan. 17, 2011 /PRNewswire/ -- Natural menopause remedies, such as DON'T PAUSE, have been proven to be extremely effective for women looking for relief from menopause symptoms.

454 Life Sciences, University of Florida, and DOE JGI Sequence Sweet Orange Genome, Publish Annotated Assembly to Public D

BRANFORD, Conn.--(BUSINESS WIRE)-- Researchers from the International Citrus Genomics Consortium announced this weekend at the Plant and Animal Genome (PAG) XIX conference in San Diego, California

Johnson & Johnson Provides Update on McNeil Consumer Healthcare Remediation; Announces Completion of Internal Assessment Phase o

NEW BRUNSWICK, N.J., Jan. 14, 2011 /PRNewswire/ -- McNeil Consumer Healthcare Division of McNeil-PPC, Inc., a Johnson & Johnson (NYSE: JNJ) company, in July 2010 submitted to the FDA a

Bristol-Myers Squibb to Announce Results for Fourth Quarter, Full Year 2010 on January 27

NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the fourth quarter and full year of 2010 on Thursday, January 27, 2011. During a conference call at 10:30

FDA limits acetaminophen in prescription combination products; requires liver toxicity warnings

FDA limits acetaminophen in prescription combination products; requires liver toxicity warnings For Immediate Release: January 13, 2011Media Inquiries: Shelly Burgess, 301-796-4651;

Actavis expands the world's only pharmaceutical manufacturing facility completely powered by renewable energy

Actavis expands the world's only pharmaceutical manufacturing facility completely powered by renewable energy - Zero carbon footprint for tablet manufacturing and packagingReykjavik, Iceland, 14

IDRI Awarded Grant from Bill and Melinda Gates Foundation to Identify Candidates for Novel TB Drugs

SEATTLE, Jan. 14, 2011 /PRNewswire-USNewswire/ -- The Infectious Disease Research Institute (IDRI) today announced it has received a multi-million dollar grant from the Bill and Melinda Gates

Genentech Informs Customers of Important Information About Triad Group's Alcohol Prep Pads

-- Consumers Alerted to Discontinue Use of Alcohol Prep Pads Packaged with Boniva® Injection, Fuzeon®, Nutropin A.Q. Pen®, Pegasys®, TNKase® Medicines -- SOUTH SAN FRANCISCO, Calif.--(BUSINESS